Rubinstein · The Journal of clinical endocrinology and metabolism 2025 · prospective controlled cohort study · n=162

Altered Microbiome Signature in Cushing's Syndrome Persists Beyond Remission.

Cited 0 times in the scientific literature.

Level 3 - non-randomized controlled study

Prospective longitudinal cohort study with pre/post-intervention follow-up and control groups

PubMed 39715347 · doi:10.1210/clinem/dgae887 · record verified 2026-08-31

What was done

Researchers prospectively analyzed stool samples from 18 patients with endogenous Cushing's syndrome (13 pituitary etiology) during active hypercortisolism and 1 to 2 years post-surgical biochemical remission. Microbial profiles generated via 16S rRNA gene sequencing (V3/V4 region) were compared against 36 obese controls (Cushing's excluded) and 108 healthy lean student controls.

What was found

Patients with active Cushing's syndrome showed a disturbed gut microbial profile compared to lean reference controls, and this dysbiosis persisted 1 to 2 years after curative surgery. The abstract provides no specific numerical values, diversity indices, taxon-specific changes, or p-values.

Why it matters

The findings suggest that hypercortisolism-induced gut dysbiosis does not spontaneously resolve shortly after biochemical cure, pointing to a potential target for post-remission microbiome-directed interventions.

Limits

The disease sample size was small (n = 18) with mixed etiologies. The abstract omits all numerical data, does not detail comparisons against the obese control cohort, and uses student controls that introduce potential age and lifestyle confounding.

Cited by